Stock listing
NASDAQ:ATRS Antares Pharma Inc Stock
Follow Antares Pharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ATRS
$5.59 USD
Close on May 24, 2022 · No longer trades
- Lowest – highest close
- $0.32 – $6.38 USDSince Jan 29, 1999 · lowest Dec 19, 2008 · highest Apr 28, 1999
Delisted NASDAQ:ATRS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ATRS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Antares Pharma Inc on 6ix
- Decks
- 36 decks · latest Mar 7, 2022
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2022) | Investor deck | 25 slides | Mar 7, 2022 |
| Investor Presentation (January 2022) | Investor deck | 25 slides | Jan 12, 2022 |
| Investor Presentation (August 2021) | Investor deck | 28 slides | Aug 18, 2021 |
| Investor Presentation (June 2021) | Investor deck | 27 slides | Jun 1, 2021 |
| Investor Presentation (March 2021) | Investor deck | 28 slides | Mar 5, 2021 |
| Investor Presentation (January 2021) | Investor deck | 28 slides | Jan 11, 2021 |
| Investor Presentation (November 2020) | Investor deck | 31 slides | Nov 12, 2020 |
| Investor Presentation (March 2020) | Investor deck | 27 slides | Mar 4, 2020 |
| Investor Presentation (January 2020) | Investor deck | 27 slides | Jan 13, 2020 |
| Investor Presentation (September 2019) | Investor deck | 22 slides | Sep 10, 2019 |
All 36 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen Smith Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Emergent BioSolutions Inc. (EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past); Acceleron Pharma Inc (Director · Nov 15, 2017 – Nov 19, 2021 · Past); Sucampo Pharmaceuticals Inc (Director · Jul 15, 2017 – Feb 13, 2018 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past) | Director · Mar 1, 2019 – May 24, 2022 · Past |
| Peter Greenleaf Other companies: Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Jan 1, 2021); Kiora Pharmaceuticals, Inc. (Director · Jul 10, 2018 – Feb 1, 2019 · Past); BioDelivery Sciences International Inc (Director · May 21, 2018 – Mar 22, 2022 · Past); Avalo Therapeutics, Inc. (Director · Mar 27, 2018 – Aug 7, 2019 · Past); Sucampo Pharmaceuticals Inc (Chief Executive Officer · Sep 30, 2017 – Feb 13, 2018 · Past) | Director · Dec 12, 2018 – May 24, 2022 · Past |
| Jack E Stover Other companies: TransCode Therapeutics, Inc. (Director · Since at least Dec 19, 2025); Profusa, Inc. (Chief Executive Officer · Since at least Dec 20, 2021); Traws Pharma, Inc. (Director · Since at least May 18, 2016); PharmaCyte Biotech, Inc. (Director · Aug 15, 2022 – Aug 15, 2022 · Past); Interpace Biosciences, Inc. (President and CEO, Director · Aug 3, 2005 – Mar 12, 2020 · Past) | President and CEO, Director · Jan 25, 2006 – May 14, 2008 · Past |
| James P. Tursi Other companies: MetaVia Inc. (Independent Director · Since at least Nov 1, 2023); Endo International PLC (Executive VP, Global R&D · Feb 24, 2022 – Jul 15, 2022 · Past); Aralez Pharmaceuticals Inc (Chief Medical Officer · Feb 5, 2016 – May 14, 2018 · Past); POZEN Inc (Chief Medical Officer · Oct 1, 2015 – Oct 1, 2015 · Past); Auxilium Pharmaceuticals Inc (Chief Medical Officer · Feb 14, 2012 – Jan 29, 2015 · Past) | EVP, Chief Medical Officer · Aug 6, 2018 – Jun 13, 2019 · Past |
| Fred M Powell Other companies: LAVA Therapeutics NV (Chief Financial Officer · Since at least Jan 1, 2025); Celator Pharmaceuticals Inc (VP and Chief Financial Officer · Jan 14, 2013 – Jul 12, 2016 · Past); BMP Sunstone CORP (Chief Financial Officer · Jan 9, 2006 – Feb 24, 2011 · Past) | Executive Vice President & CFO · Oct 31, 2016 – May 24, 2022 · Past |
| Paul Wotton Other companies: Vericel Corporation (Director · Since at least Jan 6, 2015); Ocata Therapeutics Inc (President and CEO, Director · Jul 21, 2014 – Feb 10, 2016 · Past); Genaera Corp (Director · Jun 26, 2008 – Aug 13, 2008 · Past) | President and CEO, Director · Jan 3, 2006 – May 29, 2014 · Past |
| Peter Graham Other companies: ADC Therapeutics SA (Chief Legal Officer · Since at least Jan 2, 2024); Delcath Systems, Inc. (EVP; General Counsel · Apr 20, 2010 – Nov 14, 2013 · Past); AngioDynamics, Inc. (Director · Jan 16, 2006 – Oct 25, 2006 · Past) | See Remarks · Jul 14, 2015 – May 24, 2022 · Past |
| James E Fickenscher Other companies: Zynerba Pharmaceuticals Inc (Chief Financial Officer · Sep 13, 2016 – Oct 10, 2023 · Past); Auxilium Pharmaceuticals Inc (Chief Financial Officer · Mar 10, 2006 – Jun 21, 2014 · Past) | Senior Vice President & CFO · Nov 17, 2014 – Jun 2, 2016 · Past |
| Anton Gueth Other companies: Spectrum Pharmaceuticals Inc (Director · Mar 27, 2012 – Dec 19, 2012 · Past) | Director · May 10, 2007 – May 24, 2022 · Past |
| Kaushik J Dave Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (CEO and Interim CFO, Director · Sep 16, 2013 – Mar 14, 2017 · Past) | Executive Vice President · May 6, 2013 – Jun 3, 2013 · Past |
All 15 people
| Person | Seat |
|---|---|
| Robert Apple Other companies: Kazia Therapeutics Ltd (Chairman · Since at least Jan 8, 2026) | President and CEO, Director · Feb 9, 2006 – May 24, 2022 · Past |
| Dario Carrara | Senior Vice President (1) · Jan 25, 2006 – Dec 7, 2010 · Past |
| Jacques Gonella | Director · Jan 3, 2006 – Feb 26, 2019 · Past |
| Marvin Samson | Director · May 22, 2013 – Jan 10, 2020 · Past |
| Peter L Sadowski | Senior Vice President · Nov 11, 2010 – May 17, 2012 · Past |
Log in to ask 6ix AI your own questions about Antares Pharma Inc.